IRIS
MADEDDU, Denise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 82
NA - Nord America 21
AS - Asia 8
AF - Africa 1
Totale 112
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 43
US - Stati Uniti d'America 21
IE - Irlanda 18
FR - Francia 8
CN - Cina 5
NL - Olanda 4
CZ - Repubblica Ceca 3
DE - Germania 3
FI - Finlandia 1
IN - India 1
SD - Sudan 1
SE - Svezia 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 112
Salva come PNG Salva come JPEG
Città #
Dublin 18
Parma 16
Columbus 6
Boardman 5
Ann Arbor 3
Medolla 3
Milan 3
Rome 3
Ashburn 2
Bremen 2
Casina 2
Naples 2
Pavia 2
Shanghai 2
Bacoli 1
Bologna 1
Borås 1
Cagliari 1
Dong Ket 1
Fayetteville 1
Helsinki 1
Izmir 1
Manipal 1
Piacenza 1
Reggio Nell'emilia 1
Siena 1
Tappahannock 1
Totale 82
Salva come PNG Salva come JPEG
Nome #
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells., file e177fbc5-d274-50b0-e053-d805fe0adaee 32
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC, file e177fbc6-8be1-50b0-e053-d805fe0adaee 21
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines, file e177fbc4-3e0a-50b0-e053-d805fe0adaee 20
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-5aef-50b0-e053-d805fe0adaee 9
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors, file e177fbc6-bb46-50b0-e053-d805fe0adaee 5
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells, file e177fbc7-4245-50b0-e053-d805fe0adaee 5
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol, file e177fbc5-44df-50b0-e053-d805fe0adaee 4
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC, file e177fbc7-b35d-50b0-e053-d805fe0adaee 3
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN, file e177fbc5-953c-50b0-e053-d805fe0adaee 2
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer, file e177fbc5-efd1-50b0-e053-d805fe0adaee 2
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-56f9-50b0-e053-d805fe0adaee 2
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC, file e177fbc7-a02e-50b0-e053-d805fe0adaee 2
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value, file e177fbc7-a515-50b0-e053-d805fe0adaee 2
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma, file 9dd76aa2-b75f-4677-a83e-b7095c78021c 1
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS, file e177fbc4-4075-50b0-e053-d805fe0adaee 1
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations., file e177fbc4-8faf-50b0-e053-d805fe0adaee 1
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients, file e177fbc7-2935-50b0-e053-d805fe0adaee 1
Totale 113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202219 0 5 0 3 1 0 6 0 0 0 1 3
2022/202348 3 0 1 4 2 4 2 2 22 1 6 1
2023/202432 1 1 0 6 0 1 7 3 2 3 8 0
Totale 113